Schedule 13D ownership disclosure
CYTOTHERAPEUTICS INC/DE
Security class unavailable
Event date: 2017-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-17-006904
- Form type
- SC 13D
- Filer
- Gadot Harel
- CIK
- CIK 1690103
- Filed
- Jun 20, 2017
- Reporting period
- Jun 08, 2017
- Description
- Schedule 13D beneficial ownership